An association between microvascular endothelial dysfunction, transcardiac nitric oxide production and

S M Wildhirt1, M Weis, C Schulze

  • 1Department of Cardiac Surgery, Grosshadern Hospital, Ludwig-Maximilians University, Munich, Germany. wildhirt@hch.med.uni-muenchen.de

Insights

Early after heart transplant (HTx), 26% of patients show impaired microvascular function. This dysfunction is linked to nitric oxide (NO) production and elevated cytokines, suggesting an early target for preventing transplant coronary artery disease (TxCAD).

Area of Science:

  • Cardiology
  • Immunology
  • Transplantation Medicine

Background:

  • Endothelial dysfunction precedes transplant coronary artery disease (TxCAD) development over a year post-heart transplantation (HTx).
  • Investigating early post-HTx myocardial nitric oxide synthase (NOS) expression and nitric oxide (NO) production is crucial.
  • Assessing the relationship between vasomotor function and these early molecular changes is important for TxCAD prevention.

Purpose of the Study:

  • To determine if myocardial inducible and constitutive nitric oxide synthases (iNOS; cNOS) are expressed early after HTx.
  • To investigate cardiac nitric oxide production in early post-HTx patients.
  • To assess the relationship between endothelial and epicardial vasomotor function and these early molecular changes.

Main Methods:

  • Studied 42 heart transplant recipients 37 ± 5 days post-HTx.
  • Assessed microvascular coronary flow velocity reserve (CFVR) using Doppler flow wire (endothelium-dependent and independent).
  • Measured myocardial iNOS/cNOS gene expression, plasma nitrite, and transcardiac cytokine (TNF-α, IL-6) production.

Main Results:

  • 26.1% of patients (Group A) exhibited impaired endothelium-dependent CFVR (1.65 ± 0.23 increase).
  • Myocardial iNOS/cNOS gene expression did not differ between groups.
  • Elevated coronary sinus (CS) levels of TNF-α, IL-6, and nitrite were found in Group A, with CS nitrite correlating with CS TNF-α.

Conclusions:

  • Microvascular endothelium-dependent CFVR is impaired in 26% of patients early after HTx.
  • Cytokine activation and the NO pathway are implicated in this early vasomotor dysfunction.
  • The association between cardiac NO production and TNF-α suggests a chronic inflammatory process, a potential target for TxCAD prevention.